Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples